» Authors » Aizhan Tastanova

Aizhan Tastanova

Explore the profile of Aizhan Tastanova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 141
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rutsche D, Nanni M, Cheng P, Caflisch N, Tastanova A, Jenni C, et al.
Small Methods . 2025 Jan; e2401588. PMID: 39871784
The bioengineering of vascular networks is pivotal to create complex tissues and organs for regenerative medicine applications. However, bioengineered tissues comprising an arterial and venous plexus alongside a lymphatic capillary...
2.
Dimitriou F, Cheng P, Saltari A, Schaper-Gerhardt K, Staeger R, Haunerdinger V, et al.
Nat Cancer . 2024 Aug; 5(9):1390-1408. PMID: 39210005
Immune checkpoint inhibitors are standard-of-care for the treatment of advanced melanoma, but their use is limited by immune-related adverse events. Proteomic analyses and multiplex cytokine and chemokine assays from serum...
3.
Esposito M, Yerly L, Shukla P, Hermes V, Sella F, Balazs Z, et al.
Br J Dermatol . 2024 Jun; 191(5):775-790. PMID: 38916477
Background: Basal cell carcinoma (BCC) is the most frequently diagnosed skin cancer and the most common malignancy in humans. Different morphological subtypes of BCC are associated with a low or...
4.
Lischetti U, Tastanova A, Singer F, Grob L, Carrara M, Cheng P, et al.
Commun Biol . 2023 Aug; 6(1):830. PMID: 37563418
Multi-omics profiling by CITE-seq bridges the RNA-protein gap in single-cell analysis but has been largely applied to liquid biopsies. Applying CITE-seq to clinically relevant solid biopsies to characterize healthy tissue...
5.
Grob L, Bertolini A, Carrara M, Lischetti U, Tastanova A, Beisel C, et al.
Bioinformatics . 2023 May; 39(5). PMID: 37220897
Summary: Recently, CITE-seq emerged as a multimodal single-cell technology capturing gene expression and surface protein information from the same single cells, which allows unprecedented insights into disease mechanisms and heterogeneity,...
6.
Eichhoff O, Stoffel C, Kasler J, Briker L, Turko P, Karsai G, et al.
Cancer Res . 2023 Mar; 83(7):1128-1146. PMID: 36946761
Significance: Metabolic reprogramming in drug-resistant NRAS-mutated melanoma cells confers sensitivity to ROS induction, which suppresses tumor growth and metastasis in combination with MAPK pathway inhibitors.
7.
Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, et al.
J Exp Clin Cancer Res . 2023 Mar; 42(1):67. PMID: 36934257
Background: The combination of Programmed Cell Death 1 (PD-1) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) blockade has dramatically improved the overall survival rate for malignant melanoma. Immune checkpoint blockers (ICBs)...
8.
Restivo G, Tastanova A, Balazs Z, Panebianco F, Diepenbruck M, Ercan C, et al.
Commun Biol . 2022 Oct; 5(1):1144. PMID: 36307545
Biobanking of surplus human healthy and disease-derived tissues is essential for diagnostics and translational research. An enormous amount of formalin-fixed and paraffin-embedded (FFPE), Tissue-Tek OCT embedded or snap-frozen tissues are...
9.
Burja B, Paul D, Tastanova A, Edalat S, Gerber R, Houtman M, et al.
Front Cell Dev Biol . 2022 May; 10:872688. PMID: 35573685
We present an optimized dissociation protocol for preparing high-quality skin cell suspensions for in-depth single-cell RNA-sequencing (scRNA-seq) analysis of fresh and cultured human skin. Our protocol enabled the isolation of...
10.
Tastanova A, Ramelyte E, Balazs Z, Menzel U, Beisel C, Krauthammer M, et al.
STAR Protoc . 2021 Jun; 2(2):100581. PMID: 34151301
High cell viability and recovered cell concentration are typical quality control requirements for single-cell processing and quality data. This protocol describes procedures for sampling, live-cell biobanking, preprocessing for single-cell RNA...